pin,Extracted_Text,Extracted_Text_keywords,brand_names,generic_names
2,"Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.",['bevacizumab'],['altuzan'],['bevacizumab']
7,"Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.","['ipilimumab', 'nivolumab']","['yervoy', 'opdivo']","['ipilimumab', 'nivolumab']"
92,"EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.",['pembrolizumab'],['keytruda'],['pembrolizumab']
